These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24709255)

  • 1. Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis.
    Laghi L; Picone G; Cruciani F; Brigidi P; Calanni F; Donders G; Capozzi F; Vitali B
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3411-20. PubMed ID: 24709255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of rifaximin vaginal tablets in treatment of bacterial vaginosis: a molecular characterization of the vaginal microbiota.
    Cruciani F; Brigidi P; Calanni F; Lauro V; Tacchi R; Donders G; Peters K; Guaschino S; Vitali B
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4062-70. PubMed ID: 22585228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a microarray-based tool to characterize vaginal bacterial fluctuations and application to a novel antibiotic treatment for bacterial vaginosis.
    Cruciani F; Biagi E; Severgnini M; Consolandi C; Calanni F; Donders G; Brigidi P; Vitali B
    Antimicrob Agents Chemother; 2015 May; 59(5):2825-34. PubMed ID: 25733514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.
    Vicariotto F; Mogna L; Del Piano M
    J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis.
    Vitali B; Cruciani F; Picone G; Parolin C; Donders G; Laghi L
    Eur J Clin Microbiol Infect Dis; 2015 Dec; 34(12):2367-76. PubMed ID: 26385347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics for the treatment of women with bacterial vaginosis.
    Falagas M; Betsi GI; Athanasiou S
    Clin Microbiol Infect; 2007 Jul; 13(7):657-64. PubMed ID: 17633390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteome profiles of vaginal fluids from women affected by bacterial vaginosis and healthy controls: outcomes of rifaximin treatment.
    Cruciani F; Wasinger V; Turroni S; Calanni F; Donders G; Brigidi P; Vitali B
    J Antimicrob Chemother; 2013 Nov; 68(11):2648-59. PubMed ID: 23798671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05.
    Ngugi BM; Hemmerling A; Bukusi EA; Kikuvi G; Gikunju J; Shiboski S; Fredricks DN; Cohen CR
    Sex Transm Dis; 2011 Nov; 38(11):1020-7. PubMed ID: 21992977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
    Delgado-Diaz DJ; Tyssen D; Hayward JA; Gugasyan R; Hearps AC; Tachedjian G
    Front Cell Infect Microbiol; 2019; 9():446. PubMed ID: 31998660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Wagner-Döbler I
    Microbiome; 2017 Aug; 5(1):99. PubMed ID: 28807017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
    Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis.
    Lee CY; Cheu RK; Lemke MM; Gustin AT; France MT; Hampel B; Thurman AR; Doncel GF; Ravel J; Klatt NR; Arnold KB
    Nat Commun; 2020 Dec; 11(1):6147. PubMed ID: 33262350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
    Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P
    Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex is associated with the persistence of non-optimal vaginal microbiota following treatment for bacterial vaginosis: a prospective cohort study.
    Ratten LK; Plummer EL; Murray GL; Danielewski J; Fairley CK; Garland SM; Hocking JS; Tachedjian G; Chow E; Bradshaw CS; Vodstrcil LA
    BJOG; 2021 Mar; 128(4):756-767. PubMed ID: 33480468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composition of the vaginal microbiota in women of reproductive age--sensitive and specific molecular diagnosis of bacterial vaginosis is possible?
    Shipitsyna E; Roos A; Datcu R; Hallén A; Fredlund H; Jensen JS; Engstrand L; Unemo M
    PLoS One; 2013; 8(4):e60670. PubMed ID: 23585843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biogenic Amines Increase the Odds of Bacterial Vaginosis and Affect the Growth of and Lactic Acid Production by Vaginal
    Borgogna JC; Shardell MD; Grace SG; Santori EK; Americus B; Li Z; Ulanov A; Forney L; Nelson TM; Brotman RM; Ravel J; Yeoman CJ
    Appl Environ Microbiol; 2021 Apr; 87(10):. PubMed ID: 33674429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis.
    Deng ZL; Gottschick C; Bhuju S; Masur C; Abels C; Wagner-Döbler I
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of all Four Gardnerella vaginalis Clades Detects Abnormal Vaginal Microbiota Characteristic of Bacterial Vaginosis More Accurately than Putative G. vaginalis Sialidase A Gene Count.
    Shipitsyna E; Krysanova A; Khayrullina G; Shalepo K; Savicheva A; Guschin A; Unemo M
    Mol Diagn Ther; 2019 Feb; 23(1):139-147. PubMed ID: 30721449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Lactobacillus and Gardnerella vaginalis from women with or without bacterial vaginosis and their relationships in gnotobiotic mice.
    Teixeira GS; Carvalho FP; Arantes RME; Nunes AC; Moreira JLS; Mendonça M; Almeida RB; Farias LM; Carvalho MAR; Nicoli JR
    J Med Microbiol; 2012 Aug; 61(Pt 8):1074-1081. PubMed ID: 22539000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of contraceptive initiation on vaginal microbiota.
    Achilles SL; Austin MN; Meyn LA; Mhlanga F; Chirenje ZM; Hillier SL
    Am J Obstet Gynecol; 2018 Jun; 218(6):622.e1-622.e10. PubMed ID: 29505773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.